DSM-Firmenich AG (LON:0AC9)

Market Cap	15.50B -29.7%
Revenue (ttm)	11.15B +4.5%
Net Income	615.46M
EPS	2.33
Shares Out	n/a
PE Ratio	25.18
Forward PE	19.57
Dividend	2.12 (3.21%)
Ex-Dividend Date	May 8, 2025

Volume	462,076
Average Volume	117,596
Open	69.76
Previous Close	68.74
Day's Range	68.86 - 70.70
52-Week Range	63.76 - 108.30
Beta	n/a
RSI	63.73
Earnings Date	Feb 12, 2026

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s...

• Industry: Chemicals and Allied Products
• Founded: 1902
• Employees: 28,608
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AC9

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial numbers in EUR